Arca Biopharma | ABIO - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Amgen USD 12.04B 2.91B 2026-03
Arca Biopharma USD 49.52M 2.58M 2026-03
Biogen USD 3.38B 374.2M 2026-03
Brainstorm Cell Therapeutics USD 15K 14K 2026-03
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Capricor Therapeutics USD 105.42M 182.42M 2026-03
Cipla INR 7.96B 39.9M 2025-09
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 90.6M 83.14M 2025-12
CSL USD 2.16B 633M 2025-06
Cytokinetics USD 129.84M 7.32M 2026-03
Daiichi Sankyo JPY 542.16B 97.68B 2025-09
Gilead Sciences USD 7.56B 234M 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
Grifols EUR 979.78M 334.84M 2024-12
Laboratory Of America USD 981.1M 448.8M 2026-03
Myriad Genetics USD 124.4M 25.2M 2026-03
Otsuka Holdings JPY 534.64B 123.53B 2025-12
Pfizer USD 1.7B 561M 2026-03
United Therapeutics USD 1.28B 277.4M 2026-03